DPAGT1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.378200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.936600E-01
Normal-vs-Stage2
7.245600E-01
Normal-vs-Stage3
1.786230E-01
Normal-vs-Stage4
5.540200E-01
Stage1-vs-Stage2
6.164800E-01
Stage1-vs-Stage3
2.756200E-01
Stage1-vs-Stage4
5.435600E-01
Stage2-vs-Stage3
3.359800E-02
Stage2-vs-Stage4
5.160800E-01
Stage3-vs-Stage4
1.307170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.778800E-01
Normal-vs-AfricanAmerican
8.154200E-02
Normal-vs-Asian
7.840400E-01
Caucasian-vs-AfricanAmerican
4.638300E-02
Caucasian-vs-Asian
7.140000E-01
AfricanAmerican-vs-Asian
2.088600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.515000E-01
Normal-vs-Female
8.126600E-01
Male-vs-Female
7.993600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.195400E-01
Normal-vs-Age(41-60Yrs)
5.479200E-01
Normal-vs-Age(61-80Yrs)
9.668800E-01
Normal-vs-Age(81-100Yrs)
5.656600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.731600E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.422200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.532780E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.009700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.570400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.322800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.742400E-01
Normal-vs-Daily Drinker
9.858600E-01
Normal-vs-Weekly Drinker
8.432200E-01
Normal-vs-Occasional Drinker
7.801200E-01
Normal-vs-Social Drinker
8.923200E-01
Non Drinker-vs-Daily Drinker
9.167600E-01
Non Drinker-vs-Weekly Drinker
7.190000E-01
Non Drinker-vs-Occasional Drinker
6.352800E-01
Non Drinker-vs-Social Drinker
8.960400E-01
Daily Drinker-vs-Weekly Drinker
8.121400E-01
Daily Drinker-vs-Occasional Drinker
5.994000E-01
Daily Drinker-vs-Social Drinker
8.278600E-01
Weekly Drinker-vs-Occasional Drinker
4.200600E-01
Weekly Drinker-vs-Social Drinker
5.788000E-01
Occasional Drinker-vs-Social Drinker
7.274800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.708800E-01
Normal-vs-Grade 2
1.323230E-01
Normal-vs-Grade 3
1.087000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.316000E-01
Grade 1-vs-Grade 3
9.765900E-02
Grade 1-vs-Grade 4
3.708800E-01
Grade 2-vs-Grade 3
3.460200E-01
Grade 2-vs-Grade 4
1.323230E-01
Grade 3-vs-Grade 4
1.087000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.674200E-01
Normal-vs-NonDiabetic
7.591400E-01
Diabetic-vs-NonDiabetic
6.366100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.516600E-01
Normal-vs-NoPancreatitis
9.033400E-01
Pancreatitis-vs-NoPancreatitis
2.029000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.977200E-01
Normal-vs-N1
7.932400E-01
N0-vs-N1
9.855200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.433000E-01
Normal-vs-TP53-NonMutant
9.488800E-01
TP53-Mutant-vs-TP53-NonMutant
3.581400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
